Related Experiment Video

Updated: May 20, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

PEPFAR scale-up of pediatric HIV services: innovations, achievements, and challenges

Elaine J Abrams1, R J Simonds, Surbhi Modi

  • 1ICAP, Mailman School of Public Health, Columbia University, New York, NY, USA. eja1@columbia.edu

Journal of Acquired Immune Deficiency Syndromes (1999)
|July 17, 2012
PubMed

Insights

The President's Emergency Plan for AIDS Relief (PEPFAR) significantly expanded pediatric HIV treatment access globally. This initiative improved testing, care, and medication availability for children in high-burden nations.

Area of Science:

  • Global Health
  • Pediatric Infectious Diseases
  • Public Health Initiatives

Background:

  • HIV/AIDS profoundly impacts children worldwide, with millions infected and hundreds of thousands on treatment.
  • Antiretroviral treatment is crucial for managing pediatric HIV and improving outcomes.

Purpose of the Study:

  • To describe the efforts of the President's Emergency Plan for AIDS Relief (PEPFAR) in expanding pediatric HIV treatment access.
  • To highlight the impact of PEPFAR on the global pediatric HIV epidemic through case studies.

Main Methods:

  • PEPFAR supports host governments and partners to expand HIV services for children.
  • Initiatives include improved testing for pregnant women, early infant diagnosis, and enhanced clinician training.
  • Public-private partnerships increased medication availability for pediatric HIV treatment.

Main Results:

  • Expanded access to HIV testing and treatment for pregnant women to prevent vertical transmission.
  • Increased availability of early infant diagnosis for HIV-exposed infants.
  • Improved training and resources for healthcare providers delivering pediatric HIV care.

Conclusions:

  • PEPFAR has demonstrably expanded access to lifesaving antiretroviral treatment for children living with HIV.
  • The initiative has made significant strides in combating the pediatric HIV epidemic in resource-limited settings.
  • Continued investment and strategic partnerships are vital for sustained progress in pediatric HIV care.

More Related Videos

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals09:27

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Scale-Up Processes01:14

Scale-Up Processes

The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...